Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases

Por Muneoka, Katsumasa, Kanahara, Nobuhisa, Kimura, Shou
Publicado no SAGE Open Med Case Rep (2017)

Personality Traits as Risk Factors for Treatment-Resistant Depression

Por Takahashi, Michio, Shirayama, Yukihiko, Muneoka, Katsumasa, Suzuki, Masatoshi, Sato, Koichi, Hashimoto, Kenji
Publicado em 2013

Low Openness on the Revised NEO Personality Inventory as a Risk Factor for Treatment-Resistant Depression

Por Takahashi, Michio, Shirayama, Yukihiko, Muneoka, Katsumasa, Suzuki, Masatoshi, Sato, Koichi, Hashimoto, Kenji
Publicado em 2013

A Study of Remitted and Treatment-Resistant Depression Using MMPI and Including Pessimism and Optimism Scales

Por Suzuki, Masatoshi, Takahashi, Michio, Muneoka, Katsumasa, Sato, Koichi, Hashimoto, Kenji, Shirayama, Yukihiko
Publicado em 2014

Add-on Lamotrigine Treatment for Subsyndromal Depression after Manic or Mixed States in Bipolar Disorder Improved the Quality of Life

Por Muneoka, Katsumasa, Kon, Katsushi, Kawabe, Masaharu, Ui, Rui, Miura, Taichi, Iimura, Touta, Kimura, Shou
Publicado em 2012

Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomi...

Por Hashimoto, Tasuku, Shiina, Akihiro, Hasegawa, Tadashi, Kimura, Hiroshi, Oda, Yasunori, Niitsu, Tomihisa, Ishikawa, Masatomo, Tachibana, Masumi, Muneoka, Katsumasa, Matsuki, Satoshi, Nakazato, Michiko, Iyo, Masaomi
Publicado no Ann Gen Psychiatry (2016)